Halozyme Therapeutics Unveils Convertible Senior Notes Offering Worth $650 Million Due in 2031 and 2032 Halozyme Therapeutics, Inc. has announced a proposed offering of $650 million in convertible senior notes due in 2031 and 2032, aiming to strengthen their financial position in the market.

Halozyme Therapeutics Unveils Convertible Senior Notes Offering Worth $650 Million Due in 2031 and 2032 #United_States #San_Diego #Halozyme #Convertible_Notes #Securities_Offering

Embraer Netherlands Finance B.V. Offers $650 Million in 5.980% Notes Maturing in 2035 Embraer Netherlands Finance B.V. has successfully priced $650 million in 5.980% notes due in 2035, signaling strong financial strategy.

Embraer Netherlands Finance B.V. Offers $650 Million in 5.980% Notes Maturing in 2035 #Brazil #São_Paulo #Embraer_Finance #US_Notes #Securities_Offering